View More View Less
  • 1 Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, 210009, China
  • | 2 Key Laboratory of Drug Quality Control and Pharmacovigilance, China Pharmaceutical University, Ministry of Education, Nanjing, 210009, China
  • | 3 Department of Phytochemistry, China Pharmaceutical University, Nanjing, 210009, China
  • | 4 Jiangsu Carefree Medicinal Company Limited, Nanjing, 210016, China
Restricted access

Cross Mark


10-O-(N,N-dimethylaminoethyl)-ginkgolide B (XQ-1) is an intermediate for synthesizing 10-O-(N,N-dimethylaminoethyl)-ginkgolide B methanesulfonate (XQ-1H), which is a novel ginkgolide B derivative and is being developed as a platelet-activating factor antagonist. A specific and rapid liquid chromatographic method was developed for the quantitative analysis of XQ-1 and its three related impurities, which were 10-O-(N,N-dimethylaminoethyl)-11,12-seco-ginkgolide B (imp-1), 10-O-(N,N-dimethylaminoethyl)-11,12-seco-3,14-dehydroginkgolide B (imp-2) and 10-O-(N,N-dimethylaminoethyl)-3,14-dehydroginkgolide B (imp-3) simultaneously in XQ-1 samples. Chromatographic separation was achieved on a CN band stationary phase, with the mobile phase consisting of methanol and 20 mM dipotassium hydrogen phosphate (pH 7.5) (50:50, υ/υ) in isocratic elution. The flow rate was 1.0 mL min−1 and detector was set at 220 nm. The method was optimized by the analysis of the samples generated during the forced degradation studies. The XQ-1, imp-1, imp-2, and imp-3 were completely separated within 15 min. The resolutions (Rs) amongst four target compounds were >2. The developed method was validated with respect to specificity, linearity, accuracy, precision, and robustness. The results indicated that the simultaneous LC determination method was readily utilized as a quality control method for XQ-1 sample.

  • [1]. L.H. Hu Z.L. Chen Y.Y. Xie Y.Y. Jiang H.W. Zhen 2000 Bioorg. Med. Chem. 8 1515.

  • [2]. K.M. Maclennan C.L. Darlington P.F. Smith 2002 Prog. Neurobiol. 67 235.

  • [3]. B. Ahlemeyer J. Krieglstein 2003 Cell. Mol. Life Sci. 60 1779.

  • [4]. Y. Deng W.R. Fang Y.M. Li J. Cen F. Fang P. Lv S.B. Gong L.S. Mao 2009 Eur. J. Pharmacol. 616 43.

  • [5]. W.Y. Liu P. Li F. Feng L.S. Mao 2010 J. Pharm. Biomed. Anal. 52 603.

All Time Past Year Past 30 Days
Abstract Views 6 6 1
Full Text Views 1 0 0
PDF Downloads 0 0 0